Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma

Sao Paulo Medical Journal

Volumn 124, Issue 2, 2006, Pages 112-115

  Raimondi, Antônio Marcos ^a,b   Guimarães, Hélio Penna ^a   do Amaral, José Luiz Gomez ^a   Leal, Patrícia Helena Rocha ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Esophogectomy; Meta analysis; Methylprednisolone; Multiple organ failure; Review literature

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; INTERLEUKIN 6; METHYLPREDNISOLONE; OXYGEN; PLACEBO;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL STUDY; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; INFORMATION RETRIEVAL; KIDNEY FAILURE; LIVER FAILURE; MEDLINE; MULTIPLE ORGAN FAILURE; OXYGEN TENSION; PERIOPERATIVE PERIOD; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; REVIEW; SEPSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SYSTEMATIC REVIEW;

EID: 33746888279     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802006000200013     Document Type: Review

References (18)

1. Holte K, Kehler H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002; 195(5);694-712.
2. Takeda S, Ogawa R, Nakanishi K, et al. The effect of preoperative high dose methylprednisolone in attenuating the metabolic response after oesphageal resection. Eur J Surg. 1997;163(7):511-7.
3. Takeda S, Kim, C, Ikezaki H, et al. Preoperative administration of methylprednisolone attenuated cytokine-induced respiratory failure after esophageal resection. J Nippon Med Sch. 2003;70(1):16-20.
4. Raimondi AM. Esofagite no coto esofágico em pacientes submendos à esafagogastroplastia para tratamento do megaesôfago avançado:avaliaçtiao clínica e endoscópica a longo prazo. [Esophagitis in the esophageal stump, in patients with advanced achalasia and underwent gastric transposition: a long standing clinical and endoscopic appraisal] [dissertation]. São Paulo: Faculdade de Medicina da Universidade, de São Paulo; 2001
5. Cecconello I, Rocha JRM, Raimondi AM, Oliveira MA, Gama-Rodrigues JJ. Reflux esophagitis and ectopic columnar epithelium in the esophageal stump after cervical gastroplasty: a reappraisal based on 17 years follow-up [abstract]. Gut. 2001;49(Suppl 3)3028.
6. McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons, British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT muticentre propective cohort study. BMJ. 2003;327(7425):1192-7.
7. Rentz J, Bull D, Harpole D, et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients, J Thorac, Cardiovasc Surg. 2003; 125(5):1114-20.
8. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylrednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistane to glucocorticoids. Am J Respir Crit Care Med 2002; 165(7):983-91.
9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003:348(8): 727-34.
10. Matsutani T, Onda M, Sasajima K, Miyashita M. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res. 1998;79(2):158-63.
11. Sato N, Kneda K, Ikeda K, et al. Radomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236(2):184-90.
12. Jadad AR Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
13. Clarke M, Oxaman AD, editors. Cochrane reviewers' handbook 4.1.6. [updated January 2003]. In: The Cochrane Library The Cochrane Collaboration. Oxford: Update Software; 2003.
14. Review Manager (RevMan) [Computer program] Version 4.2.2 for Windows. Oxford, England: The Cochrane Collaboration; 2004. CD-ROM and Internet.
15. Stubbs SS. Corticosteroids and bioavailability. Transplant Proc. 1975;7(1):11-9.
16. Fisher LE, Ludwig EA, Wald JA. Sloan RR, Middleton E Jr, Jusko WJ. Pharmacokinetics and pharmacodynamic of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther. 1992;51(6):677-88.
17. Greos LS, Vichyanond P, Bloedow DC et al. Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis. 1991;144(3 Pt 1):586-92.
18. Birkmeyer JD, Stukel TA, Siewer AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003:349(22):2117-27.